CIK 0001826892
- Non-accelerated filer
- Smaller reporting company
BioAtla, Inc.
Sign in to watch- Ticker
- BCAB
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851922320
- Phone
- +1 858-558-0708
- Business address
- 11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
- 4 Open-market sale Chief Financial Officer sold 13,333 shares at an average $25.26 ($336,838)
- 4 Open-market sale Vasquez Christian sold 2,541 shares at an average $25.26 ($64,195)
- 4 Open-market sale President sold 1,580 shares at an average $25.26 ($39,916)
- 4 Open-market sale Chief Medical Officer sold 434 shares at an average $25.26 ($10,964)
- 4 Open-market sale Chief Executive Officer sold 57,640 shares at an average $25.26 ($1,456,182)
- 4 Open-market sale Director sold 450 shares at $30.00 ($13,500)
- 4 Open-market sale President sold 2,994 shares at $30.18 ($90,351)
- 4 Open-market sale Chief Medical Officer sold 592 shares at $30.39 ($17,993)
- 4 Grant or award Director acquired 267,900 shares (grant or award)
- 4 Open-market sale Director sold 450 shares at $36.82 ($16,569)
- 4 Open-market sale President sold 33,244 shares at an average $40.16 ($1,334,927)
- 4 Open-market sale Chief Medical Officer sold 6,883 shares at $39.59 ($272,496)
- 4 Open-market sale Director sold 546,709 shares at $39.65 ($21,677,012)
- 4 Open-market sale Chief Executive Officer sold 4,533 shares at $41.60 ($188,573)
- 4 Open-market sale Director sold 450 shares at $40.60 ($18,270)
- 4 Open-market sale Director sold 450 shares at $38.29 ($17,231)
- 4 Open-market sale Chief Executive Officer sold 74,269 shares at an average $39.16 ($2,908,126)
- 4 Open-market sale Director sold 400,000 shares at $39.16 ($15,664,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 13 of 15 · 293 filings